Ferret Proliferative Colitis Study Guide

Overview and Clinical Importance

Proliferative colitis (also known as proliferative bowel disease or PBD) is an infectious bacterial enteropathy affecting domestic ferrets. This condition is caused by Lawsonia intracellularis, an obligate intracellular bacterium that also causes proliferative enteritis in swine and hamsters. Historically, the causative agent was believed to be a Campylobacter-like organism (ICLO), and older literature may reference Campylobacter or Desulfovibrio species; however, current evidence identifies L. intracellularis as the primary pathogen.

The disease is characterized by mucosal hyperplasia and thickening of the intestinal wall, particularly affecting the ileum and colon. This proliferation interferes with nutrient and water absorption, leading to the characteristic clinical signs of chronic diarrhea, weight loss, and potential rectal prolapse. While relatively uncommon in modern pet ferret populations due to improved husbandry practices, PBD remains an important differential diagnosis for young ferrets presenting with gastrointestinal disease.

Etiology and Pathogenesis

Causative Agent

Lawsonia intracellularis is the confirmed etiologic agent. Key microbiological characteristics include: a Gram-negative, non-spore-forming, microaerophilic curved rod; obligate intracellular pathogen requiring actively dividing eukaryotic cells for cultivation; inability to grow on standard cell-free culture media; and closely related to the organism causing proliferative enteritis in pigs and hamsters.

Historical Note: Earlier literature described the causative agent as a Campylobacter-like organism or intracellular Campylobacter-like organism (ICLO). Experimental infection studies with Campylobacter jejuni failed to reproduce the disease, and subsequent molecular analysis identified the organism as L. intracellularis. Some studies have also implicated coinfection with intracellular Desulfovibrio species and coccidia in disease development.

Pathogenesis

The pathogenesis of proliferative colitis involves several key steps. First, oral ingestion of the bacteria occurs, with L. intracellularis surviving the acidic stomach environment. Next, the bacteria utilize polar flagella to reach the intestinal epithelium, particularly targeting immature crypt enterocytes. Bacterial invasion then occurs where L. intracellularis enters host enterocytes through a mechanism possibly involving a type III secretion system.

Once inside the cell, intracellular replication begins with bacteria proliferating by binary fission in the apical cytoplasm of infected cells. The infection causes alterations in host cell gene expression, particularly affecting Wnt/?-catenin and Notch signaling pathways. This leads to infected cells entering a hyperplastic state, retaining an immature transit-amplifying status. The result is mucosal hyperplasia with marked proliferation of immature crypt enterocytes leading to mucosal thickening.

The pathological consequences include loss of mature absorptive enterocytes and goblet cells resulting in malabsorption and maldigestion. There is impaired barrier function due to loss of cellular diversity and mucin depletion. The spread occurs primarily when infected progenitor cells give rise to infected progeny, though cell rupture and liberation of bacteria also occurs. Clinical disease manifests as chronic diarrhea, weight loss, and potential complications such as rectal prolapse.

Predisposing Factors

• Age: Young, rapidly growing ferrets (10-16 weeks) most commonly affected
• Sex: Males may be more susceptible
• Housing: Large groups under suboptimal or crowded conditions
• Stress: Environmental and nutritional stressors
• Hygiene: Poor sanitation practices
• Immune status: Older ferrets with compromised immune systems may also be affected
• Coinfection: Concurrent infection with coccidia (Eimeria furonis) may exacerbate disease

Clinical Presentation

Signalment

Classic patient: Young ferret (10-16 weeks of age), recently acquired from a pet store or breeding facility, possibly with recent history of environmental change or stress. Male ferrets may be overrepresented. Older ferrets with immunocompromising conditions can also develop PBD.

Clinical Signs

Diagnostic Approach

Clinical Diagnosis

A presumptive diagnosis is often made based on signalment (young ferret), characteristic clinical signs (chronic green/bloody diarrhea, weight loss), physical examination findings (palpably thick colon), and response to appropriate antibiotic therapy (chloramphenicol).

Diagnostic Testing

Histopathological Findings

Gross pathology: The descending colon and/or ileum is grossly thickened with reduced luminal diameter. The mucosal surface may appear corrugated with prominent longitudinal and circumferential folds.

Microscopic findings: Marked crypt hyperplasia and mucosal proliferation with immature, undifferentiated enterocytes. There is loss or marked reduction of goblet cells, and mixed inflammatory cell infiltrate in the lamina propria. Crypt abscesses may be present, along with villous atrophy, blunting, and fusion in severe cases. Penetration of mucosal glands through the muscularis mucosa into submucosa may occur.

Differential Diagnosis

Treatment

Antibiotic Therapy

Chloramphenicol is the drug of choice and produces dramatic clinical improvement. No other antibiotic has been shown to consistently resolve PBD in ferrets.

Exam Focus: Chloramphenicol 50 mg/kg PO BID for 10-21 days is the treatment of choice for ferret proliferative bowel disease. Expect dramatic improvement within days of initiating therapy. A ferret with colitis of recent onset gains 50-100 grams per day within a few days of starting treatment.

Supportive Care

• Fluid therapy: SC or IV fluids for dehydration correction
• Nutritional support: High-calorie supplements (Nutrical, Deliver 2.0), canned cat food, or meat baby food for anorectic ferrets
• GI protectants: Sucralfate if concurrent gastric ulceration suspected
• Environmental management: Clean, sanitary housing; reduce stressors
• Diet: High-quality ferret diet; ensure appropriate nutrition

Rectal Prolapse Management

Rectal prolapse associated with PBD typically resolves spontaneously as the underlying disease is treated. Surgical repair with a purse-string suture is rarely necessary. If sutures are placed, the ferret must be closely monitored to ensure ability to defecate, and sutures should be removed within 2-3 days. The prolapse may appear intermittently for weeks but generally causes no apparent distress.

Treatment of Concurrent Coccidiosis

If coinfection with Eimeria furonis is identified: Sulfadimethoxine 50 mg/kg PO on day 1, then 25 mg/kg PO daily for 9-21 days. Alternative agents include ponazuril or sulfamethoxazole/trimethoprim.

Prognosis and Outcomes

Prognosis is generally good to excellent with appropriate and timely treatment. Ferrets with mild to moderate PBD respond well to chloramphenicol therapy. However, severely affected animals may die despite treatment, particularly those with proliferative ileitis alone or in combination with colitis. Chronic cases may require long-term therapy.

Untreated PBD is fatal. Without antibiotic therapy, affected ferrets progressively deteriorate due to malabsorption, dehydration, and wasting.

Long-term considerations: Severe intestinal damage from PBD may predispose ferrets to secondary problems such as inflammatory bowel disease. Ferrets recovering from PBD should be monitored closely throughout life with appropriate diagnostics including bloodwork.

Prevention

• Sanitation: Maintain clean housing and eliminate fecal contamination promptly
• Reduce stress: Minimize environmental and nutritional stressors
• Population management: Avoid overcrowding; practice all-in/all-out management where possible
• Nutrition: Provide high-quality, species-appropriate diet
• Quarantine: Isolate new ferrets before introducing to established groups
• Colony treatment: Oral tylosin (5 mg/kg mixed in soft food once daily) may reduce PBD incidence in affected colonies, though only chloramphenicol produces dramatic improvement in sick individuals

Memory Aids and Clinical Pearls

PBD Mnemonic: "PROLAPSE"

• P - Palpably thick colon
• R - Rectal prolapse common
• O - Organism: Lawsonia intracellularis (obligate intracellular)
• L - Lawsonia is the cause (not Campylobacter)
• A - Age: Young ferrets (10-16 weeks)
• P - Proliferative mucosal hyperplasia
• S - Stool: Green, mucoid, bloody
• E - Effective treatment: Chloramphenicol 50 mg/kg BID

Key Comparison: PBD vs ECE